Premium
Cohort study links gabapentinoids with increased risk of adverse outcomes
Publication year - 2019
Publication title -
the brown university psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7532
pISSN - 1068-5308
DOI - 10.1002/pu.30480
Subject(s) - pregabalin , medicine , cohort , adverse effect , cohort study , gabapentin , population , family medicine , environmental health , psychiatry , alternative medicine , pathology
A population‐based cohort study using a within‐individual design concluded that gabapentinoids were associated with a heightened risk of numerous adverse outcomes, from suicidal behavior to injuries and traffic incidents. Risk was highest in adolescents and young adults, and risk was higher with use of pregabalin than with gabapentin, researchers reported. Study results were published online June 12 in BMJ .